bpc-157 eye drops Stable Gastric Pentadecapeptide BPC 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions BPC 157 (Body Protection Compound-157)

Many peptide- and protein-based drugs are pH-sensitive and prone to hydrolysis, deamidation, or oxidation outside their optimal pH range, which can compromise therapeutic efficacy (Illum, 2003

Proceedings of the National Academy of Sciences, 117 (31), 1836918377

Aydin 1 , Adam Hilbert 1 , Charles Majoie 3 , Wim Van Zwam 4 , Aad van der Lugt 5 , Peter Vajkoczy 2 , Dietmar Frey 1,2 1 CLAIM - Charit Lab for Artificial Intelligence in Medicine,Charit Universittsmedizin Berlin, Berlin, Germany, 2 Department of Neurosurgery, Charit Universittsmedizin Berlin, Berlin, Germany, 3 Department of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, Netherlands, 4 Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, Netherlands, 5 Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands Background and Aims: A major determinant in individual functional outcomes following a large vessel occlusion (LVO) stroke is the degree of collateral circulation

See 45 FR 72582 for initial rule establishing the orange book